Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edap Tms Sa ADR (NQ: EDAP )

2.470 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edap Tms Sa ADR

< Previous 1 2 3 4 Next >
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
From EDAP TMS S.A.
Via GlobeNewswire
Recap: Edap TMS Q3 Earnings
Via Benzinga
Edap TMS's Earnings Outlook
Via Benzinga
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Third Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Recap: Edap TMS Q1 Earnings
Via Benzinga
Edap TMS Earnings Preview
Via Benzinga
Edap TMS's Earnings: A Preview
Via Benzinga
EDAP to Present at the Jefferies London Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Second Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Jefferies Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces First Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
From EDAP TMS S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
From EDAP TMS S.A.
Via GlobeNewswire
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
From EDAP TMS S.A.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.